Clec9A Targeting Antibodies as a New Immunotherapy for Prostate Cancer (2015–2019)

Grant type:
United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
Researchers:
Funded by:
United States Department of Defense